(+)-Morphine attenuates the (-)-morphine-produced conditioned place preference and the μ-opioid receptor-mediated dopamine increase in the posterior nucleus accumbens of the rat

European Journal of Pharmacology

Volumn 587, Issue 1-3, 2008, Pages 147-154

  Terashvili, Maia ^a   Wu, Hsiang En ^a   Schwasinger, Emma T ^a   Hung, Kuei Chun ^a   Hong, Jau Shyong ^b   Tseng, Leon F ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

(Rat); Addiction; Dopamine; Mesolimbic system; Morphine; Opioid

Indexed keywords

DOPAMINE; ENDOMORPHIN 1; MORPHINE; MU OPIATE RECEPTOR; URETHAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENUATION; CONTROLLED STUDY; DOPAMINE RELEASE; DOSE RESPONSE; DRUG EFFECT; MALE; MICRODIALYSIS; MICROINJECTION; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM;

ANALGESICS, OPIOID; ANESTHESIA; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CONDITIONING, OPERANT; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCHEMISTRY; MALE; MICROINJECTIONS; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NUCLEUS ACCUMBENS; OLIGOPEPTIDES; RATS; RECEPTORS, OPIOID, MU; STEREOISOMERISM; VENTRAL TEGMENTAL AREA;

EID: 44349162203     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.03.020     Document Type: Article

References (37)

1. Anderson S.M., Schmidt H.D., and Pierce R.C. Administration of the D2 dopamine receptor antagonist sulpiride into the shell, but not the core, of the nucleus accumbens attenuates cocaine priming-induced reinstatement of drug seeking. Neuropsychopharmacology 31 (2006) 1452-1461
2. Bals-Kubik R., Ableitner A., Herz A., and Shippenberg T.S. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J. Pharmacol. Exp. Ther. 264 (1993) 489-495
3. Bari A.A., and Pierce R.C. D1-like and D2 dopamine receptor antagonists administered into the shell subregion of the rat nucleus accumbens decrease cocaine, but not food, reinforcement. Neuroscience 135 (2005) 959-968
4. Calabrese E.J., and Baldwin L.A. Hormesis: the dose-response revolution. Annu. Rev. Pharmacol. Toxicol. 43 (2003) 175-197
5. Devine D.P., Leone P., Pocock D., and Wise R.A. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J. Pharmacol. Exp. Ther. 266 (1993) 1236-1246
6. Diamond D.M., Bennett M.C., Fleshner M., and Rose G.M. Inverted-U relationship between the level of peripheral corticosterone and the magnitude of hippocampal primed burst potentiation. Hippocampus 2 (1992) 421-430
7. Hernandez L., Stanley B.G., and Hoebel B.G. A small removable microdialysis probe. Life Sci. 39 (1986) 2629-2637
8. Jacquet Y.F., Klee W.A., Rice K.C., Iijima I., and Minamikawa J. Stereospecific and nonstereospecific effects of (+)- and (-)-morphine: evidence for a new class of receptors. Science 198 (1977) 842-845
9. Joels M., and de Kloet E.R. Mineralocorticoid and glucocorticoid receptors in the brain. Implication for ion permeability and transmitter systems. Prog. Neurobiol. 43 (1994) 1-36
10. Joels M. Corticosteroid effects in the brain: U-shape it. Trends Pharmacol. Sci. 27 (2006) 244-250
11. Johnson S.W., and North R.A. Opioids excite dopamine neurones by hyperpolarization of local interneurons J. Neurosci. 12 (1992) 483-488
12. Kalivas P.W., and Duffy P. Effects of acute and daily neurotensin and enkephalin treatment on extracellular dopamine in the nucleus accumbens. J. Neurosci . 10 (1990) 2940-2949
13. Klitenick M.A., DeWitte P., and Kalivas P.W. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J. Neurosci. 12 (1992) 2623-2632
14. MacDonald A.F., Billington C.J., and Levine A.S. Peptides that regulate food intake, effect of the opioid antagonist naltrexone on feeding induced by DAMGO in the ventral tegmental area and in the nucleus accumbens shell region in the rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285 (2003) R999-R1004
15. Maidment N.T., Brumbaugh D.R., Rudolph V.D., Erdelyi E., and Evans E.J. Microdialysis of extracellular endogenous opioid peptides from rat brain in vivo. Neurosci. 33 (1989) 549-557
16. Maurice T. Neurosteroids and sigma1 receptor, biochemical and behavioral relevance. Pharmacopsychiatry 37 (2004) S171-S182 Suppl
17. 1 receptor function: behavioral consequences and therapeutic opportunities. Brainm. Res. Rev. 37 (2001) 116-132
18. Monnet F.P., and Maurice T. The sigma1 protein as a target for the non-genomic effects of neuro(active) steroids: molecular, physiological, and behavioral aspects. J. Pharmacol. Sci. 100 (2006) 93-118
19. Mucha R.F., and Herz A. Preference conditioning produced by opioid active and inactive isomers of levorphanol and morphine in the rat. Life Sci. 38 (1986) 241-249
20. Olmstead M.C., and Burns L.H. Ultra-low-dose naltrexone suppresses rewarding effects of opiates and aversive effects of opiate withdrawal in rats. Psychoparmacology 12 (2005) 1-6
21. Olmstead M.C., and Franklin K.B. Differential effects of ventral striatal lesions on the conditioned place preference induced by morphine or amphetamine. Neuroscience 3 (1996) 701-708
22. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1997), Academic Press, San Diego
23. Reddy D.S., and Kulkarni S.K. The effects of neurosteroids on acquisition and retention of a modified passive-avoidance learning task in mice. Brain Res 791 (1998) 108-116
24. Shippenberg T.S., and Heidbreder C. The delta-opioid receptor antagonist naltrindole prevents sensitization to the conditioned rewarding effects of cocaine. Eur. J. Pharmacol. 280 (1995) 55-61
25. Spanagel R., Herz A., and Shippenberg T.S. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathways. Proc. Natl. Acad. Sci. USA 89 (1992) 2046-2050
26. Spanagel R., Herz A., and Shippenberg T.S. The effects of opioid peptides on dopamine release in the nucleus accumbens: an in-vivo microdialysis study. J. Neurochem. 55 (1990) 1734-1740
27. Stinus L., Herman J.P., and Moal M.L. GABAergic mechanisms within the ventral tegmental area: involvement of dopaminergic (A 10) and non-dopaminergic neurons. Psychopharmacology 77 (1982) 186-192
28. Stinus L., Koob G.F., Ling N., Bloom F.E., and Moal M.L. Locomotor activation induced by infusion of endorphin into the ventral tegmental area: evidence for opiate-dopamine interactions. Proc. Natl. Acad. Sci. USA 77 (1980) 2323-2327
29. Suzuki T., Tsuji M., Mori T., Ikeda H., Misawa M., and Nagase H. Involvement of dopamine-dependent and -independent mechanisms in the rewarding effects mediated by delta opioid receptor subtypes in mice. Brain Res. 744 (1997) 327-334
30. Terashvili M., Wu H.E., Leitermann R.J., Hung K., Clithero A.D., Schwasinger E.T., and Tseng L.F. Differential conditioned place preference responses to endomorphin-1 and endomorphin-2 microinjected into the posterior nucleus accumbens shell and ventral tegmental area in the rat. J. Pharmacol. Exp. Ther. 309 (2004) 816-824
31. Terashvili M., Wu H.E., Moore R.M., Harder D.R., and Tseng L.F. (+)-Morphine and (-)-morphine stereoselectively attenuate the (-)-morphine-produced tail-flick inhibition via the naloxone-sensitive sigma receptor in the ventral periaqueductal gray of the rat. Eur. J. Pharmacol. 571 (2007) 1-7
32. Watson S.J., Trujillo K.A., Herman J.P., and Akil H. In: Goldstein A., and Springer (Eds). Molecular and cellular aspects of the drug addiction (1989), New York 29-91
33. Wise R.A., and Rompre P.P. Brain dopamine and reward. Annu. Rev. Psychol. 40 (1989) 191-225
34. Wu H.E., Thompson J., Sun H.S., Terashvili M., and Tseng L.F. Antianalgesia: stereoselective action of dextro-morphine over levo-morphine on glia in the mouse spinal cord. J. Pharmacol. Exp. Ther. 314 (2005) 1101-1108
35. 1 receptor activation in the rat. Eur. J. Pharmacol. 562 (2007) 221-226
36. Wu H.E., Hong J.S., and Tseng L.F. Stereoselective action of (+)-morphine over (-)-morphine in attenuating the (-)-morphine-produced antinociception via the naloxone-sensitive sigma receptor in the mouse. Eur. J. Pharmacol. 571 (2007) 145-151
37. Zangen A., Ikemoto S., Zadina J.E., and Wise R.A. Rewarding and psychomotor stimulant effects of endomorphin-1: anterior-posterior differences within the ventral tegmental area and lack of effect in nucleus accumbens. J. Neurosci. 22 (2002) 7225-7233